Elimination of the Richardson Waiver Means Changes . . . But To What End? (JSON)

lexblog.com/lib/0TGMDCHAview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Elimination of the Richardson Waiver Means Changes . . . But To What End?",
    "url": "https://www.lexblog.com/2025/03/19/elimination-of-the-richardson-waiver-means-changes-but-to-what-end/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-0TGMDCHA",
        "url": "https://www.lexblog.com/lib/0TGMDCHA/"
    },
    "datePublished": "2025-03-19T19:58:38-04:00",
    "dateModified": "2025-05-28T15:11:02-04:00",
    "author": {
        "@type": "Person",
        "name": "Scot Hasselman, Lesley Reynolds, David Bender, Alexa Chronister, Matthew Loughran"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Administrative and Regulatory",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=26430",
    "sourceStability": "may-move"
}